AU500250B2 - Influenza vaccine - Google Patents

Influenza vaccine

Info

Publication number
AU500250B2
AU500250B2 AU77305/75A AU7730575A AU500250B2 AU 500250 B2 AU500250 B2 AU 500250B2 AU 77305/75 A AU77305/75 A AU 77305/75A AU 7730575 A AU7730575 A AU 7730575A AU 500250 B2 AU500250 B2 AU 500250B2
Authority
AU
Australia
Prior art keywords
influenza vaccine
influenza
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU77305/75A
Other versions
AU7730575A (en
Inventor
H. & Schmidt G Bachmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7730575A publication Critical patent/AU7730575A/en
Application granted granted Critical
Publication of AU500250B2 publication Critical patent/AU500250B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AU77305/75A 1974-01-14 1975-01-14 Influenza vaccine Expired AU500250B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GHGH447/74 1974-01-14
CH44774A CH589453A5 (en) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
AU7730575A AU7730575A (en) 1976-07-15
AU500250B2 true AU500250B2 (en) 1979-05-17

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77305/75A Expired AU500250B2 (en) 1974-01-14 1975-01-14 Influenza vaccine

Country Status (27)

Country Link
JP (2) JPS58407B2 (en)
AT (1) AT345449B (en)
AU (1) AU500250B2 (en)
BE (1) BE824372A (en)
CA (1) CA1049406A (en)
CH (1) CH589453A5 (en)
CS (1) CS191254B2 (en)
DD (1) DD116239A5 (en)
DE (1) DE2500785B2 (en)
DK (1) DK140003B (en)
ES (1) ES433759A1 (en)
FI (1) FI54053C (en)
FR (1) FR2257305B1 (en)
GB (1) GB1498261A (en)
HK (1) HK56380A (en)
HU (1) HU173920B (en)
IE (1) IE40794B1 (en)
IL (1) IL46426A (en)
MY (1) MY8100204A (en)
NL (1) NL166622C (en)
NO (1) NO143128C (en)
PH (1) PH14458A (en)
PL (1) PL93689B1 (en)
SE (1) SE427238B (en)
SU (1) SU616997A3 (en)
YU (1) YU41289B (en)
ZA (1) ZA75259B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (en) * 1977-07-13 1979-02-01 Sandoz Ag SUBUNIT VACCINE
JPH0688911B2 (en) * 1985-06-06 1994-11-09 国立予防衛生研究所長 Influenza vaccine and method for producing the same
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
CN101365480B (en) * 2005-11-01 2014-11-05 诺华疫苗和诊断有限两合公司 Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
EP2192917B1 (en) * 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
JP6373376B2 (en) 2013-11-15 2018-08-15 ノバルティス アーゲー Removal of residual cell culture impurities

Also Published As

Publication number Publication date
NL7500301A (en) 1975-07-16
FI54053B (en) 1978-06-30
HU173920B (en) 1979-09-28
JPS6035326B2 (en) 1985-08-14
AU7730575A (en) 1976-07-15
DD116239A5 (en) 1975-11-12
PH14458A (en) 1981-07-29
JPS56127319A (en) 1981-10-06
FR2257305B1 (en) 1982-03-19
YU5875A (en) 1984-04-30
FI750014A (en) 1975-07-15
AT345449B (en) 1978-09-11
SE7500130L (en) 1975-07-15
JPS50100224A (en) 1975-08-08
CS191254B2 (en) 1979-06-29
DK140003B (en) 1979-06-05
IL46426A0 (en) 1975-04-25
IE40794B1 (en) 1979-08-15
IL46426A (en) 1978-01-31
PL93689B1 (en) 1977-06-30
JPS58407B2 (en) 1983-01-06
IE40794L (en) 1975-07-14
NL166622C (en) 1981-09-15
DE2500785B2 (en) 1980-01-03
ES433759A1 (en) 1977-02-16
DE2500785C3 (en) 1980-09-11
FI54053C (en) 1978-10-10
NO143128C (en) 1980-12-29
ZA75259B (en) 1976-08-25
SU616997A3 (en) 1978-07-25
CA1049406A (en) 1979-02-27
NO750031L (en) 1975-08-11
MY8100204A (en) 1981-12-31
NO143128B (en) 1980-09-15
YU41289B (en) 1987-02-28
HK56380A (en) 1980-10-16
ATA21475A (en) 1978-01-15
FR2257305A1 (en) 1975-08-08
SE427238B (en) 1983-03-21
BE824372A (en) 1975-07-14
CH589453A5 (en) 1977-07-15
NL166622B (en) 1981-04-15
DE2500785A1 (en) 1975-07-31
DK140003C (en) 1979-10-29
DK1475A (en) 1975-09-01
GB1498261A (en) 1978-01-18

Similar Documents

Publication Publication Date Title
CA1027416A (en) Wingfold configuration
AU497398B2 (en) Tetanus vaccine
AU467292B2 (en) Eye-bush
AU500250B2 (en) Influenza vaccine
CA1034136A (en) O-aminosulfonyglycolic anilides
AU498810B2 (en) Influenza vaccines
AU503647B2 (en) Antipregnancy vaccine
SU565112A1 (en) Moment hydrocylinder
AU497239B2 (en) Parainfluenza virus vaccine
AU494738B2 (en) Virus subunit vaccine
AU485538B2 (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
AU490363B2 (en) Scaffolding
AU480112B2 (en) Wingfold configuration
AU489628B2 (en) Cinnoline derivatives
AU494543B2 (en) Pharmaceutical formulations
AU486500B2 (en) Xeroradiographic member
AU8054075A (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
AU482524B2 (en) Pyridoindoles
AU487545B2 (en) Handstamp
AU483104B2 (en) Dipenylpropylamines
AU489054B2 (en) Thiadiazolylimidazolidones
AU484632B2 (en) Aryloxyphenylpropylamines
AU463759B2 (en) Cyclopentanediones
AU488720B2 (en) 2-deutero-3-fluoro-alanine
AU484806B2 (en) Benzopyran-3-carbonitriles